Endogenous angiotensinergic system in neurons of rat and human trigeminal ganglia

Regulatory Peptides

Volumn 154, Issue 1-3, 2009, Pages 23-31

  Imboden, Hans ^a   Patil, Jaspal ^a   Nussberger, Juerg ^e   Nicoud, Françoise ^e   Hess, Benno ^a   Ahmed, Nermin ^a   Schaffner, Thomas ^a   Wellner, Maren ^b   Müller, Dominik ^b   Inagami, Tadashi ^c   Senbonmatsu, Takaaki ^c   Pavel, Jaroslav ^d   Saavedra, Juan M ^d  

^a UNIVERSITY OF BERN   (Switzerland)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

HPLC RIA; Neuronal angiotensin; Pain; Renin angiotensin system; Sensory system; Tissue angiotensin

Indexed keywords

ANGIOTENSIN DERIVATIVE; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; CATHEPSIN D; DIPEPTIDYL CARBOXYPEPTIDASE; MESSENGER RNA; NEUROTRANSMITTER; OCTAPEPTIDE; RENIN; SUBSTANCE P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL COUNT; CYTOPLASM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIGRAINE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; RADIOIMMUNOLOGY; RAT; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY MECHANISM; SAMPLE; TRIGEMINUS GANGLION;

ADULT; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; ANIMALS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NEURONS; RADIOIMMUNOASSAY; RATS; RATS, INBRED WKY; RNA, MESSENGER; TRIGEMINAL GANGLION;

RATTUS;

EID: 63049097959     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2009.02.002     Document Type: Article

References (57)

1. Amano T., Nakanishi H., Kondo T., Tanaka T., Oka M., and Yamamoto K. Age-related changes in cellular localization and enzymatic activities of cathepsins B, L and D in the rat trigeminal ganglion neuron. Mech Ageing Dev 83 (1995) 133-141
2. 1 receptor blockade reverses pathological hypertrophy and inflammation in brain microvessels of spontaneously hypertensive rats. Stroke 35 (2004) 1726-1731
3. Baltatu O., Loppoldt A., Hansson A., Ganten D., and Bader M. Local renin-angiotensin system in the pineal gland. Mol Brain Res 54 (1998) 237-242
4. Buck S.H., Walsh J.H., Yamamura H.I., and Burks T.F. Neuropeptides in sensory neurons. Life Sci 30 (1982) 1857-1866
5. Burkhalter J., Felix D., and Imboden H. A new angiotensinogen system in the CNS of the rat. Regulatory Pept 99 (2001) 93-101
6. Burstein R., and Jakubowski M. Unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol 493 (2005) 9-14
7. Chai C.Y., Hellmann W., Tseng C.J., Luft F.C., and Ganten D. Angiotensinogen mRNA and pressor reactions to angiotensin in brain stem areas of spontaneously hypertensive rats. Clin Exp Hypertens 15 (1993) 709-725
8. Charles J.A., Jotkowitz S., and Byrd L.H. Prevention of migraine with olmesartan in patients with hypertension/prehypertension. Headache 46 (2006) 503-507
9. Corvol P., Lamandè N., Cruz A., Celerier J., and Gasc J.M. Inhibition of angiogenesis: a new function for angiotensinogen and des (angiotensin I) angiotensinogen. Curr Hypertens Rep 5 (2003) 149-154
10. Danser A.H., van Kesteren C.A., Bax W.A., Tavenier M., Derkx F.H., Saxena P.R., and Schalekamp M.A. Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Circulation 96 (1997) 220-226
11. deGasparo M., Catt K.J., Inagami T., and Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Phramacol Rev 52 (2000) 415-472
12. DeVane C.L. Substance P: a new era, a new role. Pharmacotherapy 21 (2001) 1061-1069
13. Devor M., Amir R., and Rappaport Z.H. Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin J Pain 18 (2002) 4-13
14. Diz D.I., Block C.H., Barnes K.L., and Ferrario C.M. Correlation between angiotensin II binding sites and substance P in the canine brain stem. J Hypertens Suppl 4 (1986) 468-471
15. Dostrovsky J.O., Davis K.D., and Kawakita K. Central mechanisms of vascular headaches. Can J Physiol Pharmacol 69 (1991) 652-658
16. Dzau V.J., Ellison K.E., Brody T., Ingelfinger J., and Pratt R.E. A comparative study of the distributions of renin and angiotensinogen messenger ribonucleic acids in rat and mouse tissues. Endocrinology 120 (1987) 2334-2338
17. Edvinsson L. Innervation and effects of dilatory neuropeptides on cerebral vessels. New aspects. Blood Vessels 28 (1991) 35-45
18. Edvinsson L., and Uddman R. Neurobiology in primary headaches. Brain Res Rev 48 (2005) 438-456
19. Fior-Chadi D.R., and Fuxe K. Quantitative receptor radioautography in the study of receptor-receptor interactions in the nucleus tractus solitarii. Braz J Med Biol Res 31 (1998) 225-230
20. Frei N., Weissenberger J., Beck-Sickinger A.G., Höfliger M., Weis J., and Imboden H. Immunocytochemical localization of angiotensin II receptor subtypes and angiotensin II with monoclonal antibodies in the rat adrenal gland. Regulatory Pept 101 (2001) 149-155
21. Fukuda N., Satoh C., Hu W.Y., Soma M., Kubo A., Kishioka H., Watanabe Y., Izumi Y., and Kanmatsuse K. Production of angiotensin II by homogeneous cultures of vascular smooth muscle cells from spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 19 (1999) 1210-1217
22. Fusayasu E., Kowa H., Takeshima T., Nakaso K., and Nakashima K. Increased plasma substance P and CGRP levels, and high ACE activity in migraineurs during headache-free periods. Pain 128 (2007) 209-214
23. Hansen-Schwartz J. Cerebral vasospasm: a consideration of the various cellular mechanisms involved in the pathophysiology. Neurocrit Care 1 (2004) 235-246
24. Harrison S., and Geppetti P. Substance P. Int J Biochem Cell Biol 33 (2001) 555-576
25. Hou M., Uddman R., Tajti J., and Edvinsson L. Nociceptin immunoreactivity and receptor mRNA in the human trigeminal ganglion. Brain Res 964 (2003) 179-186
26. Imboden H., Harding J.W., Hilgenfeldt U., Celio M.R., and Felix D. Localization of angiotensinogen in multiple cell types of rat brain. Brain Res 410 (1987) 74-77
27. 1 antagonist. Stroke 33 (2002) 2297-2303
28. Kopp U.C., Cicha M.Z., and Smith L.A. Angiotensin blocks substance P release from renal sensory nerves by inhibiting PGE2-mediated activation of cAMP. Am J Physiol 285 (2003) 472-483
29. Kurdi M., De Mello W.C., and Booz G.W. Working outside the system: an update on the unconventional behavior of the renin-angiotensin system components. Int J Biochem Cell Biol 37 (2005) 1357-1367
30. Lazarov N.E. Comparative analysis of the chemical neuroanatomy of the mammalian trigeminal ganglion and mesencephalic trigeminal nucleus. Prog Neurobiol 66 (2002) 19-59
31. Lynch K.R., Simnad V.I., Ben-Ari E.T., and Garrison J.C. Localization of preangiotensinogen messenger RNA sequences in the rat brain. Hypertension 8 (1986) 540-543
32. Mazzone S.B., Hinrichsen C.F., and Geraghty D.P. Substance P receptors in brain stem respiratory centers of the rat: regulation of NK1 receptors by hypoxia. J Pharmacol Exp Ther 282 (1997) 1547-1556
33. 1 blockade normalizes cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke 31 (2000) 2478-2486
34. Nussberger J., Brunner D.B., Waeber B., and Brunner H.R. Specific measurement of angiotensin metabolites and in vitro generated angiotensin II in plasma. Hypertension 8 (1986) 476-482
35. Nussberger J., Brunner D.B., Waeber B., and Brunner H.R. True versus immunoreactive angiotensin II in human plasma. Hypertension 7 (1985) 1-7
36. Nussberger J. Circulating versus tissue angiotensin II. In: Epstein M., and Brunner H.R. (Eds). Angiotensin II receptor antagonists (2000), Hanley and Belfus Inc., Philadelphia 69-78
37. Patil J., Heiniger E., Schaffner T., Mühlemann O., and Imboden H. Angiotensinergic neurons in sympathetic coeliac ganglia innervating rat and human mesenteric resistance blood vessels. Regulatory Pept 147 (2008) 82-87
38. Paul M., Mehr A.P., and Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86 (2006) 747-803
39. Paul M., Wagner D., Metzger R., Ganten D., Lang R.E., Suzuki F., Murakami K., Burbach J.H.P., and Ludwig G. Quantification of renin mRNA in various mouse tissues by a novel solution hybridization assay. J Hypertens 6 (1988) 247-252
40. Paul M., Wagner J., and Dzau V.J. Gene expression of the renin-angiotensin system in human tissues: quantitative analysis by the polymerase chain reaction. J Clin Invest 91 (1993) 2058-2064
41. Paxinos G., and Charles W. The Rat Brain in Stereotaxic Coordinates - The New Coronal Set (1986), Academic Press, Australia 60
42. Pechlivanova D.M., and Stoynev A.G. Diurnal variation in the effect of angiotensin II on nociception. Methods Find Exp Clin Pharmacol 29 (2007) 423-426
43. Pelegrini-da-Silva A., Martins A.R., and Prado W.A. A new role for the renin-angiotensin system in the rat periaqueductal gray matter: angiotensin receptor-mediated modulation of nociception. Neuroscience 132 (2005) 453-463
44. Peters J., Farrenkopf R., Clausmeyer S., Zimmer J., Kantachuvesiri S., Sharp M.G., and Mullins J.J. Functional significance of prorenin internalization in the rat heart. Circ Res 90 (2002) 1135-1141
45. Pinto Y.M., Buikema H., van Gilst W.H., Scholtens E., van Geel P.P., de Graeff P.A., Wagner J., and Paul M. Cardiovascular endorgan damage in Ren-2 transgenic rat compared to spontaneously hypertensive rats. J Mol Med 75 (1997) 371-377
46. Reuss S. Trigeminal innervation of the mammalian pineal gland. Microsc Res Tech 46 (1999) 305-309
47. Rocha I., Brás-Rosário L., Amparo-Barros M., and Silva-Carvalho L. Angiotensin AT1 receptor antagonist losartan and the defence reaction in the anaesthetised rat. Effect on the carotid chemoreflex. Exp Physiol 88 (2003) 309-314
48. Saye J.A., Ragsdale N.V., Carey R.M., and Peach M.J. Localization of angiotensin peptide-forming enzymes of 3T3-F442A adipocytes. Am J Physiol 264 (1993) 1570-1576
49. Schrader H., Stovner L.J., Helde G., Sand T., and Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomized, placebo controlled, crossover study. Br Med J 322 (2001) 19-22
50. Singh V.P., Baker K.M., and Kumar R. Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production. Am J Physiol Heart Circ Physiol 294 (2008) 1675-1684
51. Tronvik E., Stovner L.J., Helde G., Sand T., and Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker (candesartan cilexetil): a rando-mized, placebo controlled, crossover study. J Am Med Assoc 289 (2003) 65-69
52. 2) in rat brain. Am J Physiol 261 (1991) 209-216
53. Von Lutterotti N., Catanzaro D.F., Sealey J.E., and Laragh J.H. Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation 89 (1994) 493-498
54. Wu W., Zhang Y., Ballew J.R., Fink G., and Wang D.H. Development of hypertension induced by subpressor infusion of angiotensin II: role of sensory nerves. Hypertension 36 (2000) 549-552
55. Yang G., Gray T.S., Sigmund C.D., and Cassell M.D. The angiotensinogen gene is expressed in both astrocytes and neurons in murine central nervous system. Brain Res 817 (1999) 123-131
56. Yan Y., Chen R., Pitarresi T., Sigmund C.D., Gross K.W., Sealey J.E., Laragh J.H., and Catanzaro D.F. Kidney is the only source of human plasma renin in 45-kb human renin transgenic mice. Circ Res 83 (1998) 1279-1288
57. 1 receptor blockade abolishes brain microvascular inflammation and heat shock protein responses in hypertensive rats. J Cereb Blood Flow Metab 25 (2005) 878-886